학술논문
Pembrolizumab (pembro) plus axitinib (axi) versus sunitinib as first-line therapy for locally advanced or metastatic renal cell carcinoma (mRCC): phase Ill KEYNOTE-426 study.
Document Type
Journal
Author
Powles, Thomas; Plimack, Elizabeth R.; Stus, Viktor; Gafanov, Rustem Airatovich; Hawkins, Robert E.; Nosov, Dmitry; Pouliot, Frederic; Alekseev, Boris Yakovlevich; Soulieres, Denis; Melichar, Bohuslav; Vynnychenko, Ihor; Kryzhanivska, Anna; Bondarenko, Igor; Azevedo, Sergio Jobim; Borchiellini, Delphine; Shou, Qiong; Perini, Rodolfo F.; Chen, Mei; Atkins, Michael B.; Rini, Brian I.
Source
Subject
Language
English
ISSN
15277755